XYOSTED (AUTOINJECTOR) Drug Patent Profile

✉ Email this page to a colleague

▶ Start for $1
Remove trial restrictions

When do Xyosted (autoinjector) patents expire, and what generic alternatives are available?

Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. There are eighteen patents protecting this drug.

This drug has sixty-nine patent family members in thirteen countries.

The generic ingredient in XYOSTED (AUTOINJECTOR) is testosterone enanthate. There are sixty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the testosterone enanthate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Xyosted (autoinjector)

A generic version of XYOSTED (AUTOINJECTOR) was approved as testosterone enanthate by WATSON PHARMS INC on December 31^st, 1969.

Try it Free

Summary for XYOSTED (AUTOINJECTOR)

International Patents:	69
US Patents:	18
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for XYOSTED (AUTOINJECTOR)
DailyMed Link:	XYOSTED (AUTOINJECTOR) at DailyMed

Drug patent expirations by year for XYOSTED (AUTOINJECTOR)

Pharmacology for XYOSTED (AUTOINJECTOR)

Drug Class	Androgen
Mechanism of Action	Androgen Receptor Agonists

Anatomical Therapeutic Chemical (ATC) Classes for XYOSTED (AUTOINJECTOR)

G03BA	3-oxoandrosten (4) derivatives
G03B	ANDROGENS
G03	SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
G	Genito-urinary system and sex hormones

US Patents and Regulatory Information for XYOSTED (AUTOINJECTOR)

XYOSTED (AUTOINJECTOR) is protected by eighteen US patents.

Patents protecting XYOSTED (AUTOINJECTOR)

Needle assisted jet injection administration of testosterone compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Injection device with cammed RAM assembly
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Needle assisted jet injection device having reduced trigger force
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Prefilled syringe injector
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Testosterone ester triglyceride formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Needle assisted injection device having reduced trigger force
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Injection device with cammed ram assembly
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Needle assisted injection administration of testosterone compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Hematocrit modulation through needle assisted jet injection of testosterone
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Syringe shock absorber for use in an injection device
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Prefilled syringe jet injector
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Needle assisted jet injection device having reduced trigger force
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-003	Sep 28, 2018		RX	Yes	Yes	See Plans and Pricing	See Plans and Pricing	Y			See Plans and Pricing
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-002	Sep 28, 2018		RX	Yes	Yes	See Plans and Pricing	See Plans and Pricing	Y			See Plans and Pricing
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-003	Sep 28, 2018		RX	Yes	Yes	See Plans and Pricing	See Plans and Pricing	Y			See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for XYOSTED (AUTOINJECTOR)

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-003	Sep 28, 2018	See Plans and Pricing	See Plans and Pricing
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-001	Sep 28, 2018	See Plans and Pricing	See Plans and Pricing
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-002	Sep 28, 2018	See Plans and Pricing	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for XYOSTED (AUTOINJECTOR)

See the table below for patents covering XYOSTED (AUTOINJECTOR) around the world.

Subscribe to access the full database, or Try it Free
Country	Patent Number	Title	Estimated Expiration
Canada	2957679	AMORTISSEUR DE CHOCS POUR SERINGUE, DESTINE A ETRE UTILISE DANS UN DISPOSITIF D'INJECTION (A SYRINGE SHOCK ABSORBER FOR USE IN AN INJECTION DEVICE)	See Plans and Pricing
China	1212867		See Plans and Pricing
World Intellectual Property Organization (WIPO)	0009186		See Plans and Pricing
>Country	>Patent Number	>Title	>Estimated Expiration

Remove trial restrictions ▶ Start for $1